Photo of Anthony (Anthony) Laurence Zietman, MD

Anthony (Anthony) Laurence Zietman, MD

  • Associate Director, Harvard Radiation Oncology Residency Program
  • Director, GU Service


Accepting New Patients



Radiation Oncology

Centers & Specialties

Cancer Center

Clinical Interests
  • Genitourinary (GU) cancer
Medical Education
  • MD, University of London
  • Residency, Massachusetts General Hospital|Residency, Westminster Hospital
  • Fellowship, Massachusetts General Hospital|Fellowship, Middlesex Hospital
Board Certifications
  • Radiation Oncology
  • Boston: Massachusetts General Hospital
Insurances Accepted
  • Aetna Health Inc.
  • Beech Street
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • Centene/Celticare
  • Cigna (PAL #'s)
  • Fallon Community HealthCare
  • Great-West Healthcare (formally One Health Plan)
  • Harvard Pilgrim Health Plan - ACD
  • Harvard Pilgrim Health Plan - PBO
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • MassHealth
  • Medicare
  • Medicare - ACD
  • Neighborhood Health Plan - ACD
  • Neighborhood Health Plan - PBO
  • OSW - Maine
  • OSW - New Hampshire
  • OSW - New York
  • OSW - Rhode Island
  • OSW - Vermont
  • Private Health Care Systems (PHCS)
  • Railroad Medicare
  • Railroad Medicare - ACD
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Healthcare (non-HMO) - PBO
Patient Age Group

Edit Profile


Dr Zietman received his undergraduate training at Oxford University in the UK and then went to medical school at the Middlesex Hospital, London University graduating in 1983. After residencies in internal medicine and clinical oncology he moved to the Massachusetts General Hospital in Boston, USA for a fellowship in radiation biology. Since joining the staff he has authored over 100 original articles and reviews on many aspects of GU cancer. His particular research interests are in the specific roles of active surveillance, brachytherapy, hormone therapy, and proton beam therapy in the treatment of prostate cancer. He also has a long-standing interest in the organ-sparing management of bladder cancer. He is currently the Jenot and William Shipley Professor of Radiation Oncology at Harvard Medical School, President of the American Society for Radiation Oncology (ASTRO), and a trustee of the American Board of Radiology.

Edit Profile

Research & Publications


Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS, Barry MJ, Zietman A.L., O'Leary M, Walker-Corkery E, Yao SL. Outcomes of localized prostate cancer following conservative management. JAMA 16:302 1202-9 2009

Zietman A.L., Bae K., Slater J.D., Shipley W.U., Efstathiou J.A., Coen J.J., Bush D.A., Lunt M., Spiegel D.Y., Skowronski R., Jabola B.R., Rossi C.J. A randomized trial comparing conventional dose conformal radiation therapy with high-dose in early stage adenocarcinoma of the prostate. Long-term results from Proton Radiaiton Oncology Group (PROG)/American College of Radiology (ACR) 95-09. J. Clin. Oncol. (in press) 2009.

Zietman A.L.. The Titanic and The Iceberg: prostate proton therapy and healthcare economics. J. Clin. Oncol. 25: 3565-66, 2007.

Zietman A.L.. Evidence-based medicine, conscience-based medicine, and the management of low-risk prostate cancer.J. Clin Oncol. 27:4935-6, 2009

Edit Profile


Genitourinary Cancer Center
55 Fruit Street
Boston MA, 02114
Phone: 617-724-1158
Fax: 617-643-1740
Clark Center for Radiation Oncology
100 Blossom Street
Boston MA, 02114-2606
Phone: 617-724-1160
Fax: 617-726-3603

Edit Profile

Back to Top